Hunting a Changing Virus
The Scientist - July 01, 2021
Libusha Kelly, Ph.D., describes SARS-CoV-2 sequencing efforts at Einstein and Montefiore and calls for a robust national genomic sequencing program to help scientists detect, understand, and stay ahead of new and developing viral variants. Dr. Kelly is associate professor of systems & computational biology and of microbiology & immunology.
Gut Bacteria Feast on the Pills We Pop
Chemical & Engineering News - September 10, 2019
Libusha Kelly, Ph.D., whose lab investigates how the gut microbiome interacts with different drugs, explains how microbes act “like tiny chemists.” Dr. Kelly is associate professor of systems & computational biology and of microbiology & immunology.
Gut bacteria can stop cancer drugs from working
Nature - June 15, 2017
Libusha Kelly, Ph.D., and computational biology student Leah Guthrie discuss their study on individuals’ microbiomes and their effect on the body’s metabolism of the chemotherapy drug irinotecan. Dr. Kelly is assistant professor in the departments of systems & computational biology and microbiology & immunology.